14. In section 132 of the Act (general interpretation provisions), in subsection (1)—
(a)before the definition of “analysis”, insert the following definition—
““Advisory Body” has the meaning given to it by paragraph 1 of Schedule 1A to this Act;”,
(b)in the definition of “the Commission”, for “Medicines Commission” substitute “Commission for Human Medicines”;
(c)after the definition of “enforcement authority”, insert the following definition—
““Expert Advisory Group” means an Expert Advisory Group established under paragraph 3 or 4 of Schedule 1A to this Act;”;
(d)after the definition of “herd”, insert the following definition—
““the Homoeopathic Regulations” means the Medicines (Homoeopathic Medicinal Products for Human Use) Regulations 1994(1)”;
(e)after the definition of “manufacture”, insert the following definition—
““the Marketing Authorisation Regulations” means the Medicines for Human Use (Marketing Authorisations Etc.) Regulations 1994;”;
(f)in the definition of “the time allowed”, for “section 21(8)” substitute “section 21(12)”.